Prevalence of cervical neoplastic lesions and human papilloma virus infection in Egypt: National cervical cancer screening project

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Abd El All, Howayda S ^a   Refaat, Amany ^a   Dandash, Khadiga ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547884288     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-12     Document Type: Review

References (70)

1. Murray CJL, Lopez AD: Global health statistics. Boston, Harvard School of Public Health on behalf of WHO and the World Bank 1996.
2. Stewart BW, Kleihues P: Cancers of the female reproductive tract. In WHO Cancer Report Lyon, France. IARC; 2003:215-222.
3. El Mosselhy MH, Moselhy MM, Amin A, Ouda-Pasha E, Abdel Hamid, Hussein MH: Prevelance of reproductive tract infections among married women of reproductive age. National Population Council/El Galaa Teaching Hospital, Egypt; 1998.
4. Younis N, Khattab H, Zurayk H, el-Mouelhy M, Amin MF, Farag AM: A community study of gynecological and related morbidities in rural Egypt. Stud Fam Plann 1993, 24:175-186.
5. Mokhtar N: Cancer Pathology Registry 1985-1989. Department of Pathology. NCI, Cairo, Egypt; 1991.
6. National Cancer Registry: The National Cancer Registry Newsletter. Ministry of Health and Population, Egypt; 2002.
7. Abd El All H, Nada G, Awaad HK, El Ayaat A: Natural killer cells in human cervical carcinoma. Master Degree Thesis, Suez Canal University, Ismailia, Egypt; 1987.
8. Abd El All H, Prade M, Khatab T, Awaad HK, Ghaly AF: Immunological study of NK cells in cervical carcinoma. In Ph.D. Thesis Faculty of Medicine, Suez Canal University, Ismailia, Egypt; 1992.
9. Ahmed MI, Salahy EE, Fayed ST, El-Hefnawy NG, Khalifa A: Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem 2001, 34:491 -498.
10. Youssef AF, Fayad MM, Shafeek AED: Bilharziasis of the cervix uteri. BJOG 1970, 77:847-851.
11. Sayed el-Ahl SA, el-Wakil HS, Kamel NM, Mahmoud MS: A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women. J Egypt Soc Parasitol 2002, 32:167-178.
12. Zur Hausen H: Intracellular surveillance of persisting viral infections. Lancet 1986, 30:489-491.
13. Zur Hausen H: Papilloma viruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989, 49:4677-46851.
14. Zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996, 1288:55-78.
15. Zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92:690-698.
16. Han CP, Tsao YP, Sun CA, Ng HT, Chen SL: Human papillomavirus, cytomegalovirus and herpes simplex virus infections for cervical cancer in Taiwan. Cancer Lett 1997, 120:217-221.
17. Rezza G, Giuliani M, Branca M, Benedetto A, Migliore G, Garbuglia, D'Ubaldoc C, Pezzotti P, Cappiello G, Pomponi-Formiconi D, Suligoi B, Schiesari G, Giocomini G: Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol 1997, 13:937-943.
18. Viikki M, Pukkala E, Nieminen P, Hakama M: Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000, 39:71-75.
19. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Birk P: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)positive and high-risk HIV-negative women. J Natl Cancer Inst 1999,91:226-236.
20. Lovejoy NC: Precancerous and cancerous cervical lesions: the multicultural "male" risk factor. Oncol Nurs Forum 1992, 21:497-504.
21. Bosch FX, Castellsague X, Muñoz N, de Sanjose S, Ghaffari AM, Gonzalez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, Guerrero E, Shah KV: Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996, 88:1060-1067.
22. Bosch FX, Lorincz A, Munoz N, Meijer Cj, Shah KV: The causal relation between human papillomavirus and cervical cancer, J Clin Pathol 2002, 55:244-265.
23. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M: A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002, 94:1406-1414.
24. Markowska J, Fischer N, Fischer Z, Warchol JB: Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. Eur J Gynaecol Oncol 2002,23:511-513.
25. Moubayed P, Ziehe A, Peters J, Mwakyoma H, Schmidt D: Carcinoma of the uterine cervix associated with schistosomiasis and induced by human papillomaviruses, Int J Gynaecol Obstet 1995, 49:175-179.
26. de Sanjose S, Bosch FX, Munoz N, Tafur L, Gili M, Izarzugaza I, Izquierdo A, Navarro C, Vergara A, Munoz MT, Ascunce N, Shah KV: Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain. Am J Public Health 1996, 86:1532-1538.
27. de Sanjosé S, Bosch FX, Muñoz N, Shah K: Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997, 138:309-317.
28. Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groóme PA: Associations between community income and cancer incidence in canada and the united states. Cancer 2000, 89:901-912.
29. Wellensiek N, Moodley M, MoodleyJ, Nkwanyana N: Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. IntJ Gynecol Cancer 2002, 12:376-382.
30. Weiderpass E, Pukkala E, Vasama-Neuvonen K, Kauppinen T, Vainio H, Paakkulainen H, Boffetta P, Partanen T: Occupational expo7sures and cancers of the endometrium and cervix uteri in Finland. Am J lnd Med 2001, 39:572-580.
31. Ramaswamy G, Krishnamoorthy L: levels in breast cancer and cancer of the uterine cervix. Nutr Cancer 1996, 25:173-177.
32. El Zanaty F, Way A: EDHS 2000: Egypt Demographic and Health Survey, Ministry of Health and Population. National Population Council, Egypt; 2001.
33. Solomon D: The Bethesda System for reporting cervical/vaginal cytologic diagnosis: an overview. Int J Gynecol Pathol 1991, 10:323-325.
34. Concensus morphologique sur les néoplasies du coluterin, Paris-Tolbiac. Archives d'Anatomie et de Cytologie Pathologiques 1991, 39:186-222.
35. Malik SN, Wilkinson EJ, Drew PA, Bennet BB, Hardt NS: Do qualifiers of ASCUS distinguish between low- and high risk patients? Acta Cyto 1999,43:376-380.
36. Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A: Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear. Acta Cytol 2000, 44:576-586.
37. Casper GR, Ostor AG, Quinn MA: A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997, 64:166-170.
38. Cenci M, Mancini R, Nofroni I, Vecchione A: Endocervical atypical glandular cells of undetermined significance. I, Morphometry and cytologic characterization of cases that "cannot rule out adenocarcinoma in situ". Acta Cytol 2000, 44:319-326.
39. Tavassoli FA, Devilee P: Pathology and Genetics. Tumors of the breast and female genital organs. WHO classification of tumours 2003, 6:.
40. Pitts M, Clarke T: Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002, 17:706-714.
41. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J: Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003, 79:320-322.
42. Miller AB, Nareer S, Fonn S, Brandup-Lukanon A, Rakshanda R, Cronje H, Sankaranarayanan R, Korolcltchouk , Syrjanen K, Singer A, Onsrud M: Report on consensus conference on cervical cancer screening and management. Int J Gyn Obst 2000, 86:440-447.
43. Geng L, Connolly DC, lsacson C, Ronnett BM, Cho KR: Atypical immature metaplasia (AIM) of the cervix: is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol 1999,30:345-351.
44. Park JJ, Genest DR, Sun D, Crum CP: Atypical immature metaplastic-like proliferations of the cervix: diagnostic reproducibility and viral (HPV) correlates. Hum Pathol 1999, 30:1161-1165.
45. Quddus MR, Zhang S, Sung CJ, Liu F, Neves T, Struminsky J, Singer DB: Utility of HPV DNA detection in thin-layer, liquid-based tests with atypical squamous metaplasia. Acta Cytol 2002, 46:808-812.
46. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, Mcintosh KM, Pawlick GF, Hiatt RA: Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999, 281:1605-1610.
47. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KS, Snijders PJF, Chris JLM, Meijer CJLM, the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. New England J Medicine 2003, 348:518-527.
48. Hammad MM, Jones HW 3, Zayed M: Low prevalence of cervical intraepithelial neoplasia among Egyptian females. Gynecol Oncol 1987, 28:300-304.
49. Komoditi C: Cervical and Corpus Uterine Cancer. In Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER Edited by: Freedman LS, Edwards BK, Ries LA, Young JL. National Cancer Institute. NIH Pub. No. 06-5873. Bethesda, MD; 2005:83-90.
50. Altaf FJ: Pattern of cervical smear cytology in the western region of Saudia Arabia. Annals Saudi Med 2001, 21:94-96.
51. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA: Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002, 23:429-432.
52. Lalaoui K, El Mzibri M, Amrani M, Belabbas MA, Lazo PA: Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control. Clin Microbiol Infect 2003, 9:144-148.
53. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A: The Prevalence of Human Papillomavirus in Cervical Cancer in Iran. Asian Pac J Cancer Prev 2003, 3:69-72.
54. Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, Ghaderi A: High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res 2003, 9:121-125.
55. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S: Human Papilloma virus types in invasive carcinoma worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
56. Williams MA, Kenya PR, Mati JK, Thomas DB: Risk factors for invasive cervical cancer in Kenyan women. Int J Epidemiol 1994, 23:906-912.
57. Biswas LN, Manna B, Maiti PK, Sengupta S: Sexual risk factors for cervical cancer among rural Indian women: a case-control study. Int J Epidemiol 1997, 26:491-495.
58. Murthy NS, Mathews A: Risks for pre-invasive lesions of the cervix. Eur J Concer Prev 2000, 9:5-14.
59. Svare El, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ: Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002, 78:215-218.
60. Roteli-Martins CM, Panetta K, Alves VA, Siqueira SA, Syrjanen KJ, Derchain SF: Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 1998,77:678-682.
61. Moodley M, Moodley J, Chetty R, Herrington CS: The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 2003, 13:103-1 10.
62. Birner P, Bachtiary B, Dreier B, Schindl M, Joura EA, Breitenecker G, Oberhuber G: Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol 2001, 14:702-709.
63. Roteli-Martins CM, Alves VA, Santos RT, Martinez EZ, Syrjanen KJ, Derchain SF: Value of morphological criteria in diagnosing cervical HPV lesions confirmed by in situ hybridization and hybrid capture assay. Pathol Res Pract 2001, 197:677-682.
64. Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH, Snijders PJ: Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 2004, 102:11-18.
65. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J: New Technologies for Cervical Cancer Working Group. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natí Cancer Inst 2006, 98:765-774.
66. Lie AK, Skjeldestad FE, Hagen B, johannessen E, Skarsvag S, Haugen OA: Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia. APMIS 1997, 105:1 15-120.
67. Lie AK, lsaksen CV, Skarsvag S, Haugen OA: Human papillomavirus (HPV) in high-grade cervical intraepithelial neoplasia (CIN) detected by morphology and polymerase chain reaction (PCR): a cytohistologic correlation of 277 cases treated by laser conization. Cytopathology 1999, 10:1 12-121.
68. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ: Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV. Diagn Cytopathol 2003,29:149-155.
69. Qureshi MN, Bolick D, Ringer PJ, Spagler FL, Zimmerman G: HPV testing in liquid cytology specimens: comparison of analytic sensitivty and specificity for in situ hybridization and chemiluminescent nucleic acid testing. Acta Cyto/2005, 49:120-126.
70. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD: The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr 2002, 141:718-723.